Literature DB >> 11866454

Selection and stabilization of the RNA aptamers against the human immunodeficiency virus type-1 nucleocapsid protein.

Se Jin Kim1, Mee Young Kim, Jae Ho Lee, Ji Chang You, Sunjoo Jeong.   

Abstract

The nucleocapsid (NC) protein of the human immunodeficiency virus-1 (HIV-1) plays an important role in the encapsidation of viral RNA and assembly of viral particle. Since the NC protein is resistant for mutation, it might be an excellent target for the anti-viral therapy. RNA aptamers that bind to the mature form of the NC protein were isolated from a RNA library. Surface plasmon resonance measurement and gel shift assay showed that the RNA aptamers specifically bind to the NC protein with high affinity and compete for the psi RNA binding to the NC protein. Mapping of the RNA aptamer showed at least two sites for the protein binding, suggesting a multiple and cooperative binding by the NC to RNA. In addition, the circular form of RNA avidly binds to the NC protein as a linear counter does. Stabilized RNA aptamer is expected to act as an inhibitor for the viral packaging.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11866454     DOI: 10.1006/bbrc.2002.6521

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

1.  Development of DNA aptamers using Cell-SELEX.

Authors:  Kwame Sefah; Dihua Shangguan; Xiangling Xiong; Meghan B O'Donoghue; Weihong Tan
Journal:  Nat Protoc       Date:  2010-06-03       Impact factor: 13.491

2.  A structural linkage between the dimerization and encapsidation signals in HIV-2 leader RNA.

Authors:  Jean-Marc Lanchy; John D Ivanovitch; J Stephen Lodmell
Journal:  RNA       Date:  2003-08       Impact factor: 4.942

3.  Design of single-stranded nucleic acid binding peptides based on nucleocapsid CCHC-box zinc-binding domains.

Authors:  Anthony L Guerrerio; Jeremy M Berg
Journal:  J Am Chem Soc       Date:  2010-07-21       Impact factor: 15.419

Review 4.  Aptamers in HIV research diagnosis and therapy.

Authors:  Jyoti Bala; Srinivasan Chinnapaiyan; Rajib Kumar Dutta; Hoshang Unwalla
Journal:  RNA Biol       Date:  2018-02-12       Impact factor: 4.652

Review 5.  Auger radiation targeted into DNA: a therapy perspective.

Authors:  Franz Buchegger; Florence Perillo-Adamer; Yves M Dupertuis; Angelika Bischof Delaloye
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-08-08       Impact factor: 9.236

6.  In vitro selection of RNA aptamer and specific targeting of ErbB2 in breast cancer cells.

Authors:  Mee Young Kim; Sunjoo Jeong
Journal:  Nucleic Acid Ther       Date:  2011-06       Impact factor: 5.486

7.  RNA aptamers directed to human immunodeficiency virus type 1 Gag polyprotein bind to the matrix and nucleocapsid domains and inhibit virus production.

Authors:  Dhivya Ramalingam; Sonald Duclair; Siddhartha A K Datta; Andrew Ellington; Alan Rein; Vinayaka R Prasad
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

8.  Application of locked nucleic acids to improve aptamer in vivo stability and targeting function.

Authors:  Kathrin S Schmidt; Sandra Borkowski; Jens Kurreck; Andrew W Stephens; Rolf Bald; Maren Hecht; Matthias Friebe; Ludger Dinkelborg; Volker A Erdmann
Journal:  Nucleic Acids Res       Date:  2004-10-27       Impact factor: 16.971

9.  Emerging Technologies for the Treatment of COVID-19.

Authors:  Hossein Aghamollaei; Rahim Sarvestani; Hamid Bakherad; Hamed Zare; Paul C Guest; Reza Ranjbar; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  Development of a cell-based assay probing the specific interaction between the human immunodeficiency virus type 1 nucleocapsid and psi RNA in vivo.

Authors:  Soo In Jang; Young Ho Kim; Soon Young Paik; Ji Chang You
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.